Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21841 | 403 | 23.8 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
| 822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
| 21841 | 1 | DILTIAZEM//DESACETYLDILTIAZEM//DEACETYLDILTIAZEM | 403 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DILTIAZEM | authKW | 781798 | 26% | 10% | 104 |
| 2 | DESACETYLDILTIAZEM | authKW | 654858 | 3% | 79% | 11 |
| 3 | DEACETYLDILTIAZEM | authKW | 315704 | 1% | 83% | 5 |
| 4 | CAS 42399 41 7 | authKW | 101024 | 0% | 67% | 2 |
| 5 | 4 4 DICARBOXY 2 2 BIQUINOLINE ACID BICINCHONINIC ACID | authKW | 75769 | 0% | 100% | 1 |
| 6 | AMPK NF KAPPA B | authKW | 75769 | 0% | 100% | 1 |
| 7 | AMPK PGC 1 ALPHA | authKW | 75769 | 0% | 100% | 1 |
| 8 | ANTIHYPERTENSOR DILTIAZEM | authKW | 75769 | 0% | 100% | 1 |
| 9 | AORTIC COARCTATION RATS | authKW | 75769 | 0% | 100% | 1 |
| 10 | ARYLBENZYLAMIDE METHYLTHIOETHER DERIVATIVE | authKW | 75769 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 5622 | 68% | 0% | 273 |
| 2 | Chemistry, Analytical | 566 | 17% | 0% | 69 |
| 3 | Chemistry, Medicinal | 165 | 7% | 0% | 27 |
| 4 | Cardiac & Cardiovascular System | 137 | 8% | 0% | 34 |
| 5 | Toxicology | 100 | 5% | 0% | 22 |
| 6 | Biochemical Research Methods | 92 | 6% | 0% | 24 |
| 7 | Medical Laboratory Technology | 73 | 2% | 0% | 10 |
| 8 | Chemistry, Multidisciplinary | 46 | 10% | 0% | 40 |
| 9 | Peripheral Vascular Diseases | 7 | 2% | 0% | 8 |
| 10 | Veterinary Sciences | 4 | 2% | 0% | 9 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EQUIVALENCIA FARMACEUT NUCLEO CONTROLE QUALID | 75769 | 0% | 100% | 1 |
| 2 | FARMCATEDRA ENSAYO VALORAC MED | 75769 | 0% | 100% | 1 |
| 3 | FARMCATEDRA FARMACOTECNIA IND | 75769 | 0% | 100% | 1 |
| 4 | LUSOFARM | 75769 | 0% | 100% | 1 |
| 5 | PHARM NUTRIT | 75769 | 0% | 100% | 1 |
| 6 | SECT NEPHROL RENAL PHYSIOL | 75769 | 0% | 100% | 1 |
| 7 | GQM | 37884 | 0% | 50% | 1 |
| 8 | METODOS RUMENTAIS ANALISE | 37884 | 0% | 50% | 1 |
| 9 | FUNDACAO ABC | 18941 | 0% | 25% | 1 |
| 10 | HLTH PROFESSIONS | 18941 | 0% | 25% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOPHARMACEUTICS & DRUG DISPOSITION | 20798 | 6% | 1% | 23 |
| 2 | JOURNAL OF CARDIOVASCULAR MEDICINE-US | 8417 | 0% | 11% | 1 |
| 3 | JOURNAL OF CLINICAL PHARMACOLOGY | 8021 | 6% | 0% | 24 |
| 4 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 3030 | 3% | 0% | 12 |
| 5 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2405 | 2% | 0% | 7 |
| 6 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1931 | 2% | 0% | 10 |
| 7 | JOURNAL OF PHARMACOBIO-DYNAMICS | 1665 | 1% | 0% | 6 |
| 8 | THERAPEUTIC DRUG MONITORING | 1630 | 2% | 0% | 9 |
| 9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1559 | 3% | 0% | 11 |
| 10 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 1539 | 4% | 0% | 15 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MENDONCA, TF , DE BARROS, EG , PEREIRA, GR , DE ARAUJO, MB , BONFILIO, R , (2011) DEVELOPMENT AND VALIDATION OF A DISSOLUTION TEST FOR DILTIAZEM HYDROCHLORIDE IN IMMEDIATE RELEASE CAPSULES.QUIMICA NOVA. VOL. 34. ISSUE 3. P. 520 -526 | 23 | 77% | 0 |
| 2 | EL-DIDAMONY, AM , (2005) INDIRECT SPECTROPHOTOMETRIC DETERMINATION OF DILTIAZEM HYDROCHLORIDE IN PURE FORM AND PHARMACEUTICAL FORMULATIONS.CENTRAL EUROPEAN JOURNAL OF CHEMISTRY. VOL. 3. ISSUE 3. P. 520-536 | 19 | 90% | 3 |
| 3 | GEORGITA, C , ALBU, F , DAVID, V , MEDVEDOVICI, A , (2008) NONLINEAR CALIBRATIONS ON THE ASSAY OF DILITIAZEM AND TWO OF ITS METABOLITES FROM PLASMA SAMPLES BY MEANS OF LIQUID CHROMATOGRAPHY AND ESI/MS2 DETECTION: APPLICATION TO A BIOEQUIVALENCE STUDY.BIOMEDICAL CHROMATOGRAPHY. VOL. 22. ISSUE 3. P. 289 -297 | 15 | 88% | 13 |
| 4 | MOLDEN, E , BOE, GH , CHRISTENSEN, H , REUBSAET, L , (2003) HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY ANALYSIS OF DILTIAZEM AND 11 OF ITS PHASE I METABOLITES IN HUMAN PLASMA.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 33. ISSUE 2. P. 275-285 | 21 | 72% | 21 |
| 5 | TSUI, BCH , FENG, JDZ , YEUNG, PKF , (1998) PHARMACOKINETICS AND HAEMODYNAMIC EFFECT OF DILTIAZEM IN RATS: EFFECT OF ROUTE OF ADMINISTRATION.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 50. ISSUE 2. P. 183-188 | 21 | 88% | 5 |
| 6 | ASCALONE, V , LOCATELLI, M , MALAVASI, B , (1994) DETERMINATION OF DILTIAZEM AND ITS MAIN METABOLITES IN HUMAN PLASMA BY AUTOMATED SOLID-PHASE EXTRACTION AND HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY - A NEW METHOD OVERCOMING INSTABILITY OF THE COMPOUNDS AND INTERFERENCE PROBLEMS.JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS. VOL. 657. ISSUE 1. P. 133-140 | 21 | 91% | 19 |
| 7 | KOVES, EM , LAWRENCE, K , MAYER, JM , (1998) STABILITY OF DILTIAZEM IN WHOLE BLOOD: FORENSIC IMPLICATIONS.JOURNAL OF FORENSIC SCIENCES. VOL. 43. ISSUE 3. P. 587-597 | 22 | 76% | 7 |
| 8 | ZENDELOVSKA, D , STAFILOV, T , STEFOVA, M , (2003) HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF DILTIAZEM IN HUMAN PLASMA AFTER SOLID-PHASE AND LIQUID-LIQUID EXTRACTION.ANALYTICAL AND BIOANALYTICAL CHEMISTRY. VOL. 376. ISSUE 6. P. 848-853 | 15 | 88% | 16 |
| 9 | TSUI, BCH , FENG, JDZ , BUCKLEY, SJ , YEUNG, PKF , (1994) PHARMACOKINETICS AND METABOLISM OF DILTIAZEM IN RATS FOLLOWING A SINGLE INTRAARTERIAL OR SINGLE ORAL DOSE.EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. VOL. 19. ISSUE 4. P. 369-373 | 19 | 86% | 5 |
| 10 | LENEVEU, A , STHENEUR, A , BOUSQUET, A , ROUX, A , (1991) AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC TECHNIQUE FOR DETERMINING DILTIAZEM AND ITS 3 MAIN METABOLITES IN SERUM.JOURNAL OF LIQUID CHROMATOGRAPHY. VOL. 14. ISSUE 19. P. 3519-3530 | 19 | 95% | 4 |
Classes with closest relation at Level 1 |